Testing a Device for Automatically TRacking Urine and STool in an Inpatient HCT Setting (Project TRUST)

April 18, 2024 updated by: Duke University

The purpose of this study is to determine whether a prototype toilet device that we have developed can accurately and automatically track human fluid output from renal and gastrointestinal systems in the hospital. The device includes components that can be outfitted onto existing toilets.

In this study, participants hospital room will be outfitted with the prototype toilet device. Participants will use the toilet as usual throughout the duration of their inpatient stay. Sometimes output will be measured by the device, and other times output will be measured manually by nurses.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27705
        • Recruiting
        • Duke University
        • Contact:
        • Contact:
          • Phone Number: +1 919 684 8964

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Scheduled to undergo an allogeneic or autologous hematopoietic stem cell transplant for any cancer or non-cancer illness through the Duke ABMT clinic
  • Age 18-80 years
  • Karnofsky Performance Scale KPS ≥ 70
  • Able to read/write English

Exclusion Criteria:

  • Inability to use toilet device due to physical constraints, e.g. waste excreted through stoma or catheter
  • Physician recommendation that patient does not use standard urine/stool collection hat during days 1-2 of HCT conditioning

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Device
Patients use toilet device to measure fluid output and self-report event types
Device will be installed on toilet of patients will in hospital to measure all waste output.
No Intervention: Control
Collection in standard hats + nurses visually assessing fluid volumes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Mean absolute error of urine volume (in mL) as measured by device compared to standard of care nurse assessment
Time Frame: Up to 14 days
Up to 14 days

Secondary Outcome Measures

Outcome Measure
Time Frame
Correlation between daily patient fluid balance (difference between fluid input and output in mL) as measured by device measurements or standard of care nurse assessment and the change in daily weight
Time Frame: Up to 14 days
Up to 14 days
Mean absolute error of urine volume (in mL) as measured by device
Time Frame: Up to 14 days
Up to 14 days
Time (in mins) spent handling/recording patient waste
Time Frame: First 3 days of patient's HCT conditioning
First 3 days of patient's HCT conditioning
Levels of chemotherapy drugs detectable on room surfaces as measured by surface testing
Time Frame: First 3 days of patient's HCT conditioning
First 3 days of patient's HCT conditioning
Time (in mins) between nurse logging of patient urination in electronic medical records and device-based logging of patient urination
Time Frame: Up to 14 days
Up to 14 days
Percent device can correctly identify diarrhea events
Time Frame: Up to 14 days
Up to 14 days
Percent of patients who indicated device satisfaction as measured by patient survey
Time Frame: Day 3 of HCT conditioning
Day 3 of HCT conditioning
Percent of nurses who perceived lower chemotherapy exposure as measured by survey
Time Frame: After transition to Stage 2 - about 3 days after patient begins HCT conditioning
After transition to Stage 2 - about 3 days after patient begins HCT conditioning
Percent of nurses who indicated device satisfaction as measured by nurse survey
Time Frame: After transition to Stage 2 - about 3 days after patient begins HCT conditioning
After transition to Stage 2 - about 3 days after patient begins HCT conditioning
Number of patient falls as measured by patient report
Time Frame: Up to 17 days
Up to 17 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Chenyu Lin, MD, Duke University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 13, 2023

Primary Completion (Estimated)

February 1, 2025

Study Completion (Estimated)

February 1, 2025

Study Registration Dates

First Submitted

August 26, 2022

First Submitted That Met QC Criteria

August 26, 2022

First Posted (Actual)

August 29, 2022

Study Record Updates

Last Update Posted (Actual)

April 19, 2024

Last Update Submitted That Met QC Criteria

April 18, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Pro00107848

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fluid Output

Clinical Trials on Electronic Device for Toilet

3
Subscribe